Application Notes & Case Studies
-
Enhancing Drug Performance Through Lipid-Based Formulations For CNS Indication
3/11/2026
Advance CNS-penetrant therapies by optimizing oral formulations to improve bioavailability, stabilize the API, and deliver more consistent and reliable drug exposure.
-
Ensuring Consistent Quality In Pharmaceutical Water For Injection (WFI) Systems Application Note
3/6/2026
Maintaining high-quality water for injection is essential for pharmaceutical safety. Discover how strategic design, proactive maintenance, and risk-based monitoring ensure reliable results.
-
ddPCR Workflows For Gene Expression Analysis
3/5/2026
RT-ddPCR offers a powerful, flexible approach to precise RNA quantification. Learn how one-step and two-step workflows improve sensitivity and efficiency in your gene expression studies.
-
Isokinetic Sampling In Unidirectional Flow
3/5/2026
Accurate cleanroom particle monitoring requires precise isokinetic sampling. Understand how to maintain sampling accuracy and meet regulatory airflow requirements for your facility.
-
ISO/TR 14644 -21:2023 Cleanrooms And Associated Controlled Environments — Part 21: Airborne Particle Sampling Techniques.
3/5/2026
Avoid common sampling errors and ensure cleanroom compliance. Master correct probe placement and tubing configurations to align with the latest industry standards and improve data accuracy.
-
Contamination Control Strategies For Innovation And Regulatory Compliance
3/4/2026
Creating a robust contamination control strategy is essential for pharmaceutical manufacturing. Learn to align risk management and technical controls to ensure lasting regulatory compliance.
-
Assessing The Success Of CRISPR Gene Therapies Using ddPCR Technology
3/4/2026
Achieve high-fidelity results in gene therapy research. Discover how absolute quantification overcomes traditional limitations to provide the precision needed for validating CRISPR edits.
-
Contamination Control Strategy: Compressed Gas Monitoring Of Microbes
3/3/2026
Microbial survival during gas decompression is a proven risk. Learn why point-of-use monitoring is essential for Annex 1 compliance and how to ensure process gas purity in sterile environments.
-
Converting From A Spray-Dried Dispersion To A KinetiSol Formulation In <5 Months
2/26/2026
A development team quickly turned a low‑bioavailability, high‑burden formulation into a streamlined, clinically improved version, boosting exposure, simplifying manufacturing, and accelerating progress.
-
Comparing Process Development Approaches For Recombinant Proteins
2/26/2026
Explore how adding a traceless tag enables streamlined affinity purification for recombinant proteins, and how this approach compares with a conventional process in development time, recovery, and purity.